about
Compact biocompatible quantum dots via RAFT-mediated synthesis of imidazole-based random copolymer ligandCombining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System MalignanciesDiagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testingSemiconductor quantum dots as contrast agents for whole animal imaging.Incidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study.Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.Advances and challenges of nanotechnology-based drug delivery systems.Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells.The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.Breaking Down the Barriers to Precision Cancer Nanomedicine.Immune Priming of the Tumor Microenvironment by Radiation.Biodegradable quantum dot nanocomposites enable live cell labeling and imaging of cytoplasmic targets.Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties.Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas.Radiologic assessment of retropharyngeal node involvement in oropharyngeal carcinomas stratified by HPV status.Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.Lessons from immuno-oncology: a new era for cancer nanomedicine?Nanoparticle-mediated cellular response is size-dependent.Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer.Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.Non-contiguous meningeal metastases of olfactory neuroblastoma.Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.Improving immune-vascular crosstalk for cancer immunotherapy.Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-Edged Sword.Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.Surface-plasmon-coupled emission of quantum dots.Increased vessel perfusion predicts the efficacy of immune checkpoint blockade.Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.The reciprocity between radiotherapy and cancer immunotherapyStudy of Osteocyte Behavior by High-Resolution Intravital Imaging Following Photo-Induced IschemiaNCR group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma developmentTherapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery
P50
Q24615930-54ABE56D-00F3-4792-B92C-7852B9A741FEQ28072007-A74864F9-D7AD-41DB-A14E-9C1D871A04A0Q30810936-E4DA46B1-8424-4E1A-87B8-661CE1A45F20Q31127234-D54A9DA1-E5A4-4F0A-9E3B-19374379A97FQ36009443-D51600B0-FDC3-42F1-B928-6115778053F0Q36416307-DCE3DC61-497A-4FBF-A398-DBDE3ED7BCCAQ36985900-46FCD686-F5C8-450F-82C3-3E26EDFE6C56Q37068608-7D276B88-5647-4EE6-8928-B2E3D8757202Q37269471-92E3C31F-89AC-421A-B8AD-B8325E4574C0Q38918823-A4F83AC4-9425-4EAD-954D-4196B189CCC3Q39456802-1EED96D7-3A6D-48E0-9F95-3AC218A7B800Q39935958-6C17EC58-0685-4A59-AB8B-ECEAB69483F7Q40541427-BB4C6F42-AE5C-4D7C-9DE7-DDD60E823BCCQ40553911-3EFBBE6B-FDF8-4141-987F-01E34AF4E727Q40852465-9B6049BB-92D0-4647-A27B-A833595E2BA8Q40955960-73351CB4-DDCF-4775-A59B-41755E390D09Q41129801-F48E86D4-AF32-4BA6-911D-BC9FDD829260Q42264101-F3593BCA-4747-445A-B13B-D07AF0C08DEBQ42565911-50A05B35-3BAD-46E8-A277-001267A389F6Q46085540-4012683D-6DC5-4074-9EBD-34F9E7F9062AQ47223945-AFB9150D-520A-415C-BB9A-027E938E6060Q47611610-DD1FD948-51D7-4A1E-907C-05C678AEB016Q47655279-01668BA1-1ED9-46C6-989E-BB55331936C8Q47794617-828211A2-FF54-45D8-9835-B2A0DCA8E8AFQ47949037-38E39F5F-113A-4C25-88F0-CEE44504D423Q47953375-6B6F3CC7-8CCA-4B93-B4E5-75CC89A17A51Q48006302-A4E46252-9DD5-462F-9D5B-89414E1972E5Q48213002-7A142D6A-2DE7-4547-BBCD-AB3209521197Q48359533-8EEF0A8A-43BF-4CAD-82EC-84067117CA85Q50051034-352EB1BA-B0E2-49CA-ACB0-A47D344C1168Q50074220-8500DFBF-D1FA-4DAA-A6FC-AC51F8D587EAQ50651030-71AD5DC7-C548-476A-B908-34A9CC95D00EQ50951676-2A794F18-A218-4001-B429-95F50455D235Q51161333-168660BB-94F8-4A34-8285-5344EB1992C8Q52583527-44DC34B6-7379-40C2-9FE6-C226B650D931Q55287125-D1BE1A69-CF59-486D-B085-AB93DD7032A5Q58562711-CFF070DA-76C1-4BAA-9C53-7BA886D6B142Q58613146-3616B339-CC9A-41AB-8CE6-F382EBDFFEE4Q64075903-D79F5DC5-B321-4FAA-95E7-4C1A63A981ECQ64239906-71C9A967-EA66-4615-953E-268EDF2836FB
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0001-9154-633X
@en
name
Wen Jiang
@ast
Wen Jiang
@en
Wen Jiang
@es
Wen Jiang
@nl
Wen Jiang
@sl
type
label
Wen Jiang
@ast
Wen Jiang
@en
Wen Jiang
@es
Wen Jiang
@nl
Wen Jiang
@sl
prefLabel
Wen Jiang
@ast
Wen Jiang
@en
Wen Jiang
@es
Wen Jiang
@nl
Wen Jiang
@sl
P1153
P106
P1153
55868894000
56544904500
56605677500
P2798
P31
P3835
wen-jiang18
P496
0000-0001-9154-633X